on AFYREN (EPA:ALAFY)
AFYREN Secures €23 Million for Biorefinery Expansion
AFYREN, a French greentech company specializing in bio-based ingredients, has completed a €23 million share capital increase. This funding, primarily from Kemin Industries and Bpifrance, is geared towards enhancing AFYREN NEOXY, the company's innovative biorefinery. Kemin contributed €20 million, while Bpifrance invested €3 million through its Large Venture fund. The shares were offered at €2.40, reflecting a 9% premium over the recent average share price of €2.21.
The proceeds will support the plant's optimization, enabling a production capacity boost to 20 kilotons, a significant increase from the originally planned 16 kilotons. This enhancement aims to satisfy growing market demand and improve financial performance.
The investment underscores AFYREN's robust industry position and its collaboration with Kemin Industries, bolstering their shared commitment to sustainability and innovation in bio-based solutions.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news